In vitro diagnostic tests and test systems for high-throughput operation in routine labs and clinical research
Numares has raised €62M across 7 funding rounds from 6 investors, most recently a round in Dec 2022. Based in Regensburg, Germany; founded 2004; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-21 | Other | €40M | Existing investors,The European Investment Bank (EIB) | View deal → |
| 2019-10-01 | Other | €0 | — | View deal → |
| 2016-07-01 | Growth/Late | €2.0M | Bayern Kapital | View deal → |
| 2012-02-01 | Series B | €7.2M | Bayern Kapital,KfW Bankengruppe | View deal → |
| 2011-10-01 | Early VC | €7.0M | Bayern Kapital,KFW,SHS Gesellschaft f√ºr Beteiligungsmanagement | View deal → |
| 2009-12-01 | Early VC | €4.0M | — | View deal → |
| 2006-10-01 | Early VC | €2.0M | Bayern Kapital,KfW Bankengruppe | View deal → |
